Ke Pan

1.3k total citations
73 papers, 936 citations indexed

About

Ke Pan is a scholar working on Molecular Biology, Pharmacology and Plant Science. According to data from OpenAlex, Ke Pan has authored 73 papers receiving a total of 936 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 16 papers in Pharmacology and 14 papers in Plant Science. Recurrent topics in Ke Pan's work include Cholinesterase and Neurodegenerative Diseases (11 papers), Chemical synthesis and alkaloids (9 papers) and Natural product bioactivities and synthesis (8 papers). Ke Pan is often cited by papers focused on Cholinesterase and Neurodegenerative Diseases (11 papers), Chemical synthesis and alkaloids (9 papers) and Natural product bioactivities and synthesis (8 papers). Ke Pan collaborates with scholars based in China, Japan and United States. Ke Pan's co-authors include Zhi‐Qi Yin, Jian‐Guang Luo, Ling‐Yi Kong, Frank Jordan, Zhong‐Bo Zhou, Jian‐Chuan Xia, Cuihua Jiang, Jian Zhang, Jing-Jing Zhao and Tomofumi Miyamoto and has published in prestigious journals such as Journal of the American Chemical Society, SHILAP Revista de lepidopterología and Biochemistry.

In The Last Decade

Ke Pan

66 papers receiving 929 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ke Pan China 18 316 179 169 162 132 73 936
Wan‐Jung Lu Taiwan 22 479 1.5× 154 0.9× 168 1.0× 104 0.6× 155 1.2× 54 1.2k
Jiao Zheng China 21 728 2.3× 169 0.9× 188 1.1× 125 0.8× 150 1.1× 79 1.4k
Shin‐Hyung Park South Korea 19 557 1.8× 116 0.6× 104 0.6× 162 1.0× 104 0.8× 57 1.1k
Sung‐Moo Kim South Korea 20 525 1.7× 122 0.7× 188 1.1× 205 1.3× 76 0.6× 33 1.2k
Shaoyu Wu China 16 536 1.7× 101 0.6× 87 0.5× 161 1.0× 58 0.4× 54 1.0k
Kun‐Hung Shen Taiwan 19 531 1.7× 171 1.0× 152 0.9× 209 1.3× 145 1.1× 35 1.1k
Chao‐Yue Sun China 22 572 1.8× 131 0.7× 104 0.6× 159 1.0× 93 0.7× 36 1.1k
Anna Wawruszak Poland 18 586 1.9× 75 0.4× 106 0.6× 283 1.7× 164 1.2× 49 1.1k

Countries citing papers authored by Ke Pan

Since Specialization
Citations

This map shows the geographic impact of Ke Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ke Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ke Pan more than expected).

Fields of papers citing papers by Ke Pan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ke Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ke Pan. The network helps show where Ke Pan may publish in the future.

Co-authorship network of co-authors of Ke Pan

This figure shows the co-authorship network connecting the top 25 collaborators of Ke Pan. A scholar is included among the top collaborators of Ke Pan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ke Pan. Ke Pan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pan, Ke, et al.. (2025). Hepatic Encephalopathy: Current Thoughts on Pathophysiology and Management. Current Neurology and Neuroscience Reports. 25(1). 28–28. 6 indexed citations
2.
Liu, Lili, Yaping Huang, Xian Wang, et al.. (2025). Simultaneous determination of 13 representative saponins from the total saponins of Gynostemma pentaphyllum in rat plasma using LC-MS/MS for pharmacokinetic study. Journal of Pharmaceutical and Biomedical Analysis. 264. 116970–116970.
3.
Liu, Jia, Caixia Wu, Can Hu, et al.. (2025). Terpene and lignan glycosides from the leaves of Cyclocarya paliurus and their anti-inflammatory activity. Phytochemistry. 234. 114443–114443. 1 indexed citations
4.
Jiang, Cuihua, Fangfang Chen, Ke Pan, et al.. (2025). Brain endothelial HIF-1α exacerbates diabetes-associated cognitive impairment by accelerating glycolysis-driven lactate production. Acta Pharmaceutica Sinica B. 15(11). 5772–5788.
5.
Pan, Ke, et al.. (2025). Differential expression of extracellular vesicle microRNA and granulosa cell mRNA in polycystic ovary syndrome with insulin resistance. Reproductive BioMedicine Online. 51(4). 105027–105027. 2 indexed citations
6.
Kong, Xiangzhen, et al.. (2025). T2-weighted MRI high signal in cervical spondylotic myelopathy is associated with dynamic change. Journal of Orthopaedic Surgery and Research. 20(1). 360–360.
8.
Li, Heng, Jing Lv, Weilin Shi, et al.. (2024). Dopamine β-hydroxylase shapes intestinal inflammation through modulating T cell activation. Cellular Immunology. 401-402. 104839–104839. 1 indexed citations
9.
Zhang, Jinfu, Yue Wang, Ke Pan, et al.. (2024). Ovarian Torsion at 8 weeks of Gestation in a Woman with Threatened Abortion After Frozen-Thawed Embryo Transfer: A Case Report. International Journal of Women s Health. Volume 16. 2043–2050.
10.
Li, Tian, Shuying Li, Ziyuan Wang, et al.. (2023). 5-epi-ent-Kaurane diterpenoids from the aerial parts of Isodon eriocalyx and their anti-atherosclerotic potential. Phytochemistry. 209. 113621–113621. 4 indexed citations
11.
Zhu, Liping, Qingqing Wang, Jie Wang, et al.. (2023). Structurally diverse glycosides with α-glucosidase inhibitory properties from water extract of the leaves of Cyclocarya paliurus. Fitoterapia. 167. 105473–105473. 7 indexed citations
12.
Liu, Yao, Xuanxuan Zhang, Li Zhu, et al.. (2022). New triterpenoids from the Cyclocarya paliurus (Batalin) Iljinskaja and their anti-fibrotic activity. Phytochemistry. 204. 113434–113434. 11 indexed citations
13.
Huang, Yaping, Yunshan Wang, Zhiqiang Song, et al.. (2021). Dammarane-type saponins with proprotein convertase subtilisin/kexin type 9 inhibitory activity from Gynostemma pentaphyllum. Phytochemistry. 194. 113005–113005. 9 indexed citations
14.
Zhang, Hai‐Tao, Xikun Han, Chuangshi Wang, et al.. (2021). Diagnosis of infection after cardiovascular surgery (DICS): a study protocol for developing and validating a prediction model in prospective observational study. BMJ Open. 11(9). e048310–e048310. 4 indexed citations
15.
Zhang, Haitao, Lijun Yue, Zeshi Li, et al.. (2021). Risk factors for mortality in patients undergoing continuous renal replacement therapy after cardiac surgery. BMC Cardiovascular Disorders. 21(1). 509–509. 7 indexed citations
16.
Pan, Ke, He Zhang, Kai Zhong, et al.. (2021). Bilirubin adsorption versus plasma exchange for hyperbilirubinemia in patients after cardiac surgery: a retrospective study. Journal of Cardiothoracic Surgery. 16(1). 238–238. 2 indexed citations
17.
Wang, Yunshan, et al.. (2021). New dammarane-type glycosides from Gynostemma pentaphyllum and their lipid-lowering activity. Bioorganic Chemistry. 111. 104843–104843. 32 indexed citations
18.
Pan, Ke, Jian‐Guang Luo, & Ling‐Yi Kong. (2014). A new Lycopodium alkaloid from Phlegmariurus fargesii. Chinese Journal of Natural Medicines. 12(5). 373–376. 12 indexed citations
19.
Pan, Ke, et al.. (2014). Suppressive effects of total alkaloids of Lycopodiastrum casuarinoides on adjuvant-induced arthritis in rats. Journal of Ethnopharmacology. 159. 17–22. 13 indexed citations
20.
Zhou, Zhong‐Bo, et al.. (2013). Bioactive Benzofuran Neolignans from Aristolochia fordiana. Planta Medica. 79(18). 1730–1735. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026